In the interim, NICE-approved options for weight management in adults with obesity include: Orlistat (available on NHS prescription) Semaglutide 2.4 mg (Wegovy) , recommended by NICE in 2023 for use in specific patient groups (NICE technology appraisal TA875) Tirzepatide (Mounjaro) , which received NICE approval in 2024 for obesity management (NICE technology appraisal TA1026) [18] Patients seeking advice about weight management or blood pressure control should be directed to their GP in the first instance, who can assess eligibility for currently approved treatments and refer to specialist services where appropriate
Invigor Medical Help Center
Choi W, Lee J, Lee J, Lee SH, Dim S
Importantly, fat within beta cells the pancreatic cells producing insulin can lead to decreased insulin production
Peripheral artery disease (PAD) is precisely what it sounds like, a disease affecting the peripheral arteries
This is a good option if you have assistance with injection or are very experienced